Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 13/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28263648 | 0.87 | KIF11 (0.55) | KIF11ALDH1A1TSHRHTTCYP11B1 | |
| SCHEMBL9317928 | 0.83 | MAPK1 (0.41) | ALDH1A1TSHRHTTCYP3A4CYP2D6 | |
| SCHEMBL9888403 | 0.83 | SMN1; SMN2 (0.48) | ALDH1A1TSHRHTTKCNH2CYP2D6 | |
| SCHEMBL19419845 | 0.78 | CYP1A2 (0.47) | ALDH1A1TSHRHTTKCNH2CYP2D6 | |
| SCHEMBL10865897 | 0.78 | TAAR1 (0.48) | ALDH1A1TSHRHTTCYP3A4CYP2D6 | |
| SCHEMBL14954530 | 0.78 | TSHR (0.40) | KIF11ALDH1A1TSHRHTTCYP2D6 | |
| SCHEMBL27953401 | 0.78 | TSHR (0.40) | KIF11ALDH1A1TSHRHTTCYP2D6 | |
| SCHEMBL11034545 | 0.77 | KIF11 (0.48) | KIF11CYP11B1CYP11B2KCNH2CYP3A4 | |
| SCHEMBL6367386 | 0.77 | KIF11 (0.48) | KIF11CYP11B1CYP11B2KCNH2CYP3A4 | |
| SCHEMBL28954005 | 0.77 | KIF11 (0.48) | KIF11CYP11B1CYP11B2KCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101359738-B | Catalyst-loaded support used for forming electrode for fuel cell, and method of producing the same | TOYOTA MOTOR CORP | 2011-04-06 | — | — | CN | claimed |
| EP-2028706-A1 | Catalyst-loaded support used for forming electrode for fuel cell, and method of producing the same | Toyota Jidosha Kabusiki Kaisha (JP) | 2009-02-25 | — | — | EP | claimed |
| US-20090035640-A1 | Catalyst-loaded support used for forming electrode for fuel cell, and method of producing the same | TOYOTA JIDOSHA KABUSHIKI KAISHA | 2009-02-05 | — | — | US | claimed |
| CN-101359738-A | Catalyst-loaded support used for forming electrode for fuel cell, and method of producing the same | TOYOTA MOTOR CO LTD (JP) | 2009-02-04 | — | — | CN | claimed |
| US-12570774-B2 | Cycloolefin resin cured product having oxygen barrier properties | RIMTEC CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| EP-4703402-A1 | POLYMERIZABLE COMPOSITION AND MOLDED ARTICLE | RIMTEC Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224997-A1 | POLYMERIZABLE COMPOSITION AND MOLDED ARTICLE | RIMTEC株式会社 | 2024-10-31 | — | — | WO | disclosed |
| US-20240002585-A1 | CYCLOOLEFIN RESIN CURED PRODUCT | RIMTEC CORPORATION (JP) | 2024-01-04 | — | — | US | disclosed |
| US-20230322978-A1 | CYCLOOLEFIN RESIN CURED PRODUCT HAVING OXYGEN BARRIER PROPERTIES | RIMTEC CORPORATION (JP) | 2023-10-12 | — | — | US | disclosed |
| US-11710590-B2 | Superconducting coil device and method for producing same | RAILWAY TECHNICAL RESEARCH INSTITUTE (JP) | 2023-07-25 | — | — | US | disclosed |
| EP-4205968-A1 | CYCLOOLEFIN RESIN CURED PRODUCT HAVING OXYGEN BARRIER PROPERTIES | RIMTEC Corporation (JP) | 2023-07-05 | — | — | EP | disclosed |
| EP-4190836-A1 | CYCLOOLEFIN RESIN CURED PRODUCT | RIMTEC Corporation (JP) | 2023-06-07 | — | — | EP | disclosed |
| CN-101359738-A | Catalyst-loaded support used for forming electrode for fuel cell, and method of producing the same | TOYOTA MOTOR CO LTD (JP) | 2009-02-04 | — | — | CN | disclosed |
| CN-101359738-A | Catalyst-loaded support used for forming electrode for fuel cell, and method of producing the same | TOYOTA MOTOR CO LTD (JP) | 2009-02-04 | — | — | CN | disclosed |
| EP-0519631-B1 | Both-side roughened copper foil with protection film | SUMITOMO BAKELITE CO (JP) | 1998-04-15 | — | — | EP | disclosed |
| EP-0514074-B1 | Method of producing copper-clad laminated board | SUMITOMO BAKELITE CO (JP) | 1996-02-28 | — | — | EP | disclosed |
| US-5413838-A | Printed circuit board | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 1995-05-09 | — | — | US | disclosed |
| US-5286330-A | Impregnating fabric with thermosetting reins; pressing poly-amide film; peeling | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 1994-02-15 | — | — | US | disclosed |
| EP-0519631-A2 | Both-side roughened copper foil with protection film | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 1992-12-23 | — | — | EP | disclosed |
| EP-0514074-A2 | Method of producing copper-clad laminated board | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 1992-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11710590-B2 | Superconducting coil device and method for producing same | COIL, NBAS, NUP50 | KIF11 2722/4885ALDH1A1 3558/4885TSHR 4182/4885 |
| US-12570774-B2 | Cycloolefin resin cured product having oxygen barrier properties | HMOX1, GPX1, ALOX12 | KIF11 4463/4885ALDH1A1 467/4885TSHR 4714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.